Additional file 3: of Integrative omics analyses broaden treatment targets in human cancer

Clara Oh (5567483); Cynthia Ma (4609264); Cyriac Kandoth (746224); David FenyĂś (3399305); Feng Chen (25347); Jie Ning (3420689); John Dipersio (5567507); John Welch (3281673); Joshua McMichael (3568127); Kimberly Johnson (5567495); Kuan-lin Huang (473523); Li Ding (16240); Matthew Bailey (3427394); Matthew Wyczalkowski (5567489); Michael Wendl (5567498); Piyush Tripathi (5567492); Rajees Varghese (5567486); Reid Townsend (5567504); Sam Sun (5567480); Samuel Payne (5369300); Sohini Sengupta (5567477)

Additional file 3: of Integrative omics analyses broaden treatment targets in human cancer

Abstract

Figure S1. Fusions in the TCGA cohort. Figure S2. Druggable protein expression outliers using mass spectrometry. Figure S3. Co-occurring druggable mutations represent opportunities for combinational and alternative therapy. Figure S4. Druggability and Demographics. Figure S5. Potential Druggability by Cancer Type. (PDF 514Â KB) (PDF 501 kb

Similar works

Full text

Available Versions

Directory of Open Access Journals

oai:doaj.org/article:85a202f38...

Last time updated on 04/06/2019

FigShare

oai:figshare.com:article/68744...

Last time updated on 13/08/2018